17.10
0.06%
-0.010
After Hours:
17.09
-0.01
-0.06%
abrdn Healthcare Investors stock is currently priced at $17.10, with a 24-hour trading volume of 101.29K.
It has seen a -0.06% decreased in the last 24 hours and a -1.33% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $17.08 pivot point. If it approaches the $17.18 resistance level, significant changes may occur.
Previous Close:
$17.11
Open:
$17.09
24h Volume:
101.29K
Market Cap:
$865.68M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.88%
1M Performance:
-1.33%
6M Performance:
+5.23%
1Y Performance:
-0.35%
abrdn Healthcare Investors Stock (HQH) Company Profile
Name
abrdn Healthcare Investors
Sector
Industry
Phone
617-772-8500
Address
100 Federal Street, 19th Floor, Boston, MA
abrdn Healthcare Investors Stock (HQH) Latest News
Chinese, Indian Stocks Favored by abrdn on Policy Boost Hopes - Yahoo Canada Finance
Yahoo Canada Finance
Abrdn World Healthcare Fund (THW) to Issue Monthly Dividend of $0.12 on June 28th - Defense World
Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 9704 Shares - Defense World
Defense World
Abrdn readies HDFC Life exit - Mint
Mint
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $133,041.84 in Stock - MarketBeat
MarketBeat
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - The Globe and Mail
The Globe and Mail
abrdn Healthcare Investors Stock (HQH) Financials Data
There is no financial data for abrdn Healthcare Investors (HQH). Check out other stocks for more information.
About abrdn Healthcare Investors
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Cap:
|
Volume (24h):